Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Causes of Lower Gastrointestinal Bleeding in Cirrhotics: Are the Most Commonly Reported Causes the Most Common?American Journal of the Medical Sciences.  359:191-192. 2020
2020 Cholecystectomy does not worsen progression or outcomes in non-alcoholic fatty liver diseaseTranslational gastrointestinal cancer.  5. 2020
2020 Gastrointestinal stromal tumor: GIST another duodenal ulcerThe Ochsner journal.  20:236-238. 2020
2019 Survival Outcomes of Very Small Drug-Eluting Beads Used in Chemoembolization of Unresectable Hepatocellular Carcinoma 2019
2019 Hepatocellular carcinoma surveillance: An evidence-based approachWorld Journal of Gastroenterology.  25:1550-1559. 2019
2019 Case series regarding parastomal variceal bleeding: Presentation and management 2019
2018 Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patientsJGH Open.  2:317-321. 2018
2018 Effect of hepatitis c treatment on renal function in liver transplant patientsJournal of Clinical and Translational Hepatology.  6:391-395. 2018
2017 Gastric Antral Vascular Ectasia and Metabolic Syndrome: Is There a Case for an Association?American Journal of Medicine.  130:e511. 2017
2017 A rare finding of colonic malakoplakiaPractical Gastroenterology.  41:52-66. 2017
2017 Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplantHepatology International.  11:434-439. 2017
2017 Dual endoscopic technique using through- and over-the-scope clips to close a colo-gastrocutaneous fistula due to a percutaneous gastrostomy tubeEndoscopy.  49:E64-E65. 2017
2017 Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: A case series from a transplant centerEuropean Journal of Gastroenterology and Hepatology.  29:973-976. 2017
2017 Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: A retrospective study in a large urban tertiary centerEuropean Journal of Gastroenterology and Hepatology.  29:1219-1222. 2017
2016 Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver disease 2016
2015 Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver DiseaseDigestive Diseases and Sciences.  60:3788-3793. 2015
2015 Management of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology.  141:861-876. 2015
2015 Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseasesJournal of Clinical and Translational Hepatology.  3:9-16. 2015
2014 Alcoholic hepatitis and concomitant hepatitis C virus infectionWorld Journal of Gastroenterology.  20:11929-11934. 2014
2014 Surveillance for hepatocellular carcinoma: Evidence, guidelines and utilizationAmerican Journal of the Medical Sciences.  347:415-419. 2014
2013 Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: Time trends and impact on survivalTransplant International.  26:788-794. 2013

Chapter

Year Title Altmetric
2014 Variceal hemorrhage.  145-158. 2014

Investigator On

  • A Phase 2A Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients with Acute Liver Failure/Severe Acute Liver Injury (STOP-ALF)  awarded by University of Texas Southwestern Medical Center at Dallas
  • Alabama Coalition for Testing, Interventions, and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION
  • Establishing Normative Cognitive Data for UAB Medical Professionals  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University
  • Hope in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation  awarded by Johns Hopkins University
  • Introducing Palliative Care (PC) within the Treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial  awarded by Duke University
  • Private Grant  awarded by VITAL THERAPIES, INC
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC.
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC.
  • Private Grant  awarded by OCERA THERAPEUTICS, INC.
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC.
  • Private Grant  awarded by CONATUS PHARMACEUTICALS, INC.
  • Private Grant  awarded by CONATUS PHARMACEUTICALS, INC.
  • Private Grant  awarded by DOVA PHARMCEUTICALS
  • Private Grant  awarded by INTERCEPT PHARMACEUTICALS
  • Private Grant  awarded by TAKEDA PHARMACEUTICALS COMPANY LTD
  • Private Grant  awarded by OLYMPUS AMERICA
  • Private Grant  awarded by COOK MEDICAL - NEW
  • Private Grant  awarded by ARROWHEAD PHARMACEUTICALS INC.
  • Private Grant  awarded by ELI LILLY AND COMPANY
  • Private Grant  awarded by OCERA THERAPEUTICS, INC.
  • Private Grant  awarded by GALECTIN THERAPEUTICS
  • Private Grant  awarded by ELI LILLY AND COMPANY
  • Private Grant  awarded by INTERCEPT PHARMACEUTICALS
  • Private Grant  awarded by DURECT CORPORATION
  • Private Grant  awarded by GRIFOLS, INC
  • Education And Training

  • Doctor of Medicine, Cairo University 1997
  • Full Name

  • Mohamed Shoreibah